HAV VACCINES LTD has a total of 21 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Australia, EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and measurement are NYMOX PHARMACEUTICAL CORP, INSIGHT BIOPHARMACEUTICALS LTD and ATYR PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 | |
#7 | United States | 2 | |
#8 | Brazil | 1 | |
#9 | China | 1 | |
#10 | Mexico | 1 | |
#11 | New Zealand | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Analysing materials | |
#6 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Hermon-Taylor John | 17 |
#2 | Bull Timothy John | 5 |
#3 | John Hermon-Taylor | 2 |
#4 | Hermon Taylor John | 2 |
Publication | Filing date | Title |
---|---|---|
SG11202100120TA | Immunogenic composition for paratuberculosis | |
EP3568698A1 | Diagnostic | |
AU2006277828A1 | Immunogenic constructs | |
EP1062347A1 | Diagnostics and vaccines for mycobacterial infections of animals and humans |